Teva suffers legal setback in its bid to affirm Corcept patents

Teva Pharmaceutical (NYSE:TEVA) has lost its attempt to invalidate a patent for Cushing’s syndrome drug Korlym, marketed by Corcept Therapeutics (NASDAQ:CORT). The U.S. Court of Appeals for the Federal Circuit has affirmed the decision by the U.S. Patent Trial and Appeal Board (USPTO) and rejected Teva’s (TEVA) arguments, Bloomberg reports.
Picture for Teva suffers legal setback in its bid to affirm Corcept patents

Biohaven to seek FDA approval for second migraine drug after study success

Biohaven Pharmaceutical will soon ask the Food and Drug Administration for approval of its second migraine drug after a large, late-stage study showed treatment eased pain and the most bothersome headache symptoms in significantly more trial participants than did placebo. The drug, called zavegepant, works similarly to Biohaven's approved migraine...
Picture for Biohaven to seek FDA approval for second migraine drug after study success

Recession In 2022?

The Dow Jones was up nicely but Nasdaq was barely ahead. Mohammed El Erian, the Harvard economist, warns that the real risk is not inflation but a recession in 2022. Russia is surrounding Ukraine with 70,000 soldiers so there is a real war risk with the USA and the West.

6 Household Items Health Canada Wants You To Check & Then Throw Out ASAP

Health Canada has recently issued recalls on a variety of common household products, so you should definitely check to make sure that items you use aren't on the list!. Canadians are advised to stop using these six products immediately and to either safely dispose of them, return them to the place that they were purchased, or contact the company for a refund.

38 Chic, Affordable Amazon Fashion Items to Add to Cart

As a fashion lover on a budget, I’m constantly on the hunt for a bargain. Whether that’s scoring a pair of vintage Levi’s from the thrift store or snagging a dress that finally went on sale, I don’t think there’s a purchase that is more satisfying than a good deal.

Opioids Market with Future Prospects, Key Player SWOT Analysis and Forecast To 2026

The recent research report on Opioids market offers an in-depth assessment of this business space such as key development trends as well as dynamics influencing this industry outlook during the forecast period. It delivers important details such as regulatory outlook alongside regional analysis. The document also evaluates the factors that are boosting the market growth as well as provides a comprehensive SWOT analysis. Furthermore, the research contains information pertaining to limitations & challenges affecting the future remuneration as well as y-o-y growth rate of this industry.

Future Growth Of CNS Therapeutics Market by New Business Developments, Innovations, And Top Companies "“ Forecast To 2026

The research analysis of CNS Therapeutics market offers significant information regarding the major trends that define this business landscape with regards to the regional outlook and competitive scenario. The report also highlights the limitations & challenges that could hamper the industry remuneration alongside the key opportunities that will aid in business expansion. Moreover, the document provides crucial insights regarding the effect of COVID-19 pandemic on the overall market outlook.

World's biggest fashion brands linked to deforestation in the Amazon, from Zara to Fendi

A new study of the fashion industry’s convoluted supply chains has linked a number of the world’s biggest brands to deforestation in the Amazon rainforest. Conducted by, a supply chain research company, the report places a spotlight on tanneries and other companies involved in the production of leather and goods made from it in Brazil. The cattle industry is the single largest driver of deforestation in the Amazon rainforest and tropical forests globally, and Brazil has the largest cattle herd in the world, amounting to 215 million animals.

Cotopaxi Partners with Sport Factory Pacific to Lead Distribution Efforts in Australia, New Zealand and the Pacific Island Region

Get access to everything we publish when you sign up for Outside+. Salt Lake City, UT. 6th Dec. 2021 — Cotopaxi, the outdoor industry’s first venture capital-backed Benefit Corporation and Certified B Corp, and one of the fastest-growing outdoors apparel and gear brands in the North American market, is proud to announce the expansion of its global distribution strategy into the Australasian region pre-launching November 2021 and available from March 2022.
Daily Hampshire Gazette

Connecting threads: Hadley woman becomes 3rd generation to wear the same custom-made wedding gown made of Holyoke’s Skinner Satin

Denise Barstow got married in a cow pasture wearing a custom-made satin gown.Not just any gown, mind you: It’s an heirloom worn first by her grandmother and then by her mother. Her father, sixth-generation dairy farmer David Barstow of Hadley, walked her down the mowed path that served as the aisle for her wedding on Oct. 16.

Acetazolamide Market Impressive Gains including key players Teva, TARO, Zydus Pharmaceuticals

JCMR recently introduced Acetazolamide study with focused approach on market size & volumes by Application, Industry particular process, product type, players, and production & Consumption analysis considering major factors, cost Structure and regulatory factors. At present, the Acetazolamide market is developing its presence and some of the key players from the complete study are Teva, TARO, Zydus Pharmaceuticals, Lannett Company, Sun Pharmaceutical, Heritage Pharmaceuticals, Nostrum Laboratories, Accord Healthcare, Strides Pharma, West-Ward Pharmaceuticals, X-Gen Pharmaceuticals, Mylan, Emcure.
Motley Fool

2 Popular Healthcare Stocks I'd Avoid at All Costs

Generic drug manufacturers need to have steadily growing free cash flow to deliver returns for investors. Small biotechs that struggle with commercializing drugs aren't likely to grow consistently. Waiting to invest once a company's performance improves is always an option. You’re reading a free article with opinions that may differ...

Gan Teva Wraps Up its First “Semester”

Gan Teva at Ner Shalom has now been open for about three months, and students are growing tremendously under the careful supervision of the director and lead educator, Sarah Maynard. A Typical Day. Gan Teva at Ner Shalom is an outdoor, play-based early childhood education center. Each day starts with...

Field of Potential Adalimumab Biosimilar Contenders Continues to Grow

The list of potential adalimumab biosimilars has now lengthened to 10, according to a Cardinal Health summary of these products and their distinguishing features. A review of adalimumab biosimilars by Cardinal Health anticipates that possibly 2 more could be approved and launched in 2023, the year that 6 FDA-approved adalimumab biosimilars are already scheduled for launch.

Zotepine Market: Key Players, Growth, Analysis, 2021-2026

The report on Zotepine Market provides a complete briefing on strategic recommendations, trends, segmentation, use case analysis, competitive intelligence, global and regional forecast to 2026. The objective of this research is to provide a 360 holistic view of the Zotepine market and bringing insights that can help stakeholders identify the opportunities as well as challenges. The report provides the market size in terms of value and volume of the Global Zotepine Market.

Budesonide Market Demand In 2021 : Top Key Manufacturers (AstraZeneca, Teva, Mylan & More) with Leading Regions and Countries Data

Budesonide Market Insights In 2021 : [91 Pages Report] This report contains market size and forecasts of Budesonide in China, including the following market information:. China Budesonide Market Revenue, 2016-2021, 2022-2027, ($ millions) China Budesonide Market Sales, 2016-2021, 2022-2027, (M Units) China top five Budesonide companies in 2020 (%) The...